Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Conversion of shares

According to Husqvarna AB´s articles of association, owners of Class A shares have the right to have such shares converted to Class B shares. Conversion reduces the total number of votes in Husqvarna AB. When such a conversion has occurred, the company is obligated by the Act on Trading in Financial Instruments to disclose any such change. In December 2020, at the request of shareholders, 2,129 Class A shares were converted to Class B shares. The total number of votes thereafter amounts to 158,153,875.7. The total number of registered shares in the company amounts to 576,343,778

Diagnostic Services COO Benedikt von Braunmühl has decided to leave the company

Benedikt von Braunmühl has been the COO of Diagnostic Services since 2016 and is part of the Executive Management Team. Benedikt von Braunmühl has decided to leave the company for other opportunities. Benedikt von Braunmühl has six months’ standard notice period. “We are thankful for Benedikt’s contribution and development of the Diagnostic Services division during the years and wish Benedikt the best of luck with his new role”, says Fredrik Rågmark, CEO. The recruitment of a new COO for Diagnostic Services will start shortly.   For further information, please contact: Hanna

Orexo expects FDA filing of OX124 mid 2022

· OX124 is designed to reverse the effect of the most powerful synthetic opioids · Synthetic opioids are behind the majority of fatal overdoses in the US, a development expected to increase due to Covid-19 · New Drug Application (NDA) filing expected mid 2022 Uppsala, Sweden – January 29, 2021 – Orexo AB (publ.), (STO:ORX) (OTCQX:ORXOY) today announces that it is expecting to file its flagship pharmaceutical pipeline asset OX124 with the US Food and Drug Administration mid-2022. OX124 is expected to follow the FDA’s standard submission and review timelines, as the FDA did not grant

AXACTOR SE EUR 250,000,000 FRN SENIOR UNSECURED BOND ISSUE 2018/2021 - ISIN NO 001 0819725

Axactor SE has notified Nordic Trustee (in the enclosed Call Option Notice) of its intention to exercise today its call option for the remaining outstanding bonds in the Bond issue AXA01, "Axactor SE EUR 250,000,000 FRN Senior Unsecured Bond Issue 2018/2021 - ISIN NO 001 0819725". The entire Bond issue will be repaid at 100% of the Nominal Amount plus accrued interests on the redeemed amount), with settlement date 5 February 2021 (being the date falling five (5) Business Days after the date of the Call Option Notice). For additional information please contact: Kyrre Svae, Interim CFO,

COVID-19 vaccine receives positive opinion in EU

29 January 2021 15:15 GMT COVID-19 Vaccine AstraZeneca recommended for use in the EU AstraZeneca's COVID-19 vaccine has been recommended for conditional marketing authorisation (CMA) in the European Union (EU) for active immunisation to prevent COVID-19 caused by SARS-CoV-2, in individuals 18 years of age and older.   Following review of the application, the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency based its positive opinion on data from a rolling review of trial data from the primary analysis of the Phase III programme led by the

Catella AB (publ) divests its Property Asset Management-operations in France

Catella AB (publ) divests its 50.1 percent holdings in its French subsidiary Catella Asset Management SAS for a cash purchase price of SEK 154 million. The divestment will have a positive effect on profit after tax, including transaction costs, of approximately SEK 122 million during the first quarter of 2021.Catella's brand is strong and the French market is strategically important to Catella and therefore Catella will further develop its position in Asset Management in France. Catella is already exploring ways to establish new operations with potential new local partners. During the

Delete Finland Oy has completed the divestment of Delete Demolition Oy

Delete Group Oyj, Stock Exchange Release 29 January 2021 at 5.30 p.m. EETDelete Finland Oy, a group company of the Delete Group ("Delete"), has completed the divestment of Delete Demolition Oy, a subsidiary operating in the Demolition Services business area (the "Transaction"), announced on 16 December 2020. The Transaction was completed by way of Delete Finland Oy selling all the shares in Delete Demolition Oy to Lotus Maskin & Transport AB for a purchase price of EUR 7,332,625. The net proceeds to Delete resulting from the Transaction are approximately EUR 4.6 million after the deduction

SpectrumOne AB byter Certified Adviser

SpectrumOne AB (publ) (“Bolaget”) meddelar att Bolaget har ingått avtal med Aktieinvest FK AB (“Aktieinvest”) avseende tjänsten som Certified Adviser (”CA”). Aktieinvest tillträder som CA den 1 februari 2021. Fram till dess kommer Mangold Fondkommission AB fortsatt agera CA åt Bolaget.For further information contact:Fredric ForsmanChairman of the Board +46 73 978 78 44 fredric@spectrumone.com Certified Adviser:Mangold Fondkommission AB (556585-1267) Box 55 691 102 15 Stockholm Telefon: +46 8 503 015 50 ca@mangold.se www.mangold.se

Change in number of shares and votes in HEXPOL AB (publ.)

The long-term incentive program for employees (”Warrants Program 2016/2020”) implemented at the annual general meeting on 29 April 2016 has resulted in the number of shares and votes in the company having increased during January 2021 by 235,566 shares of series B and corresponding number of votes, through conversion of subscription warrants into new shares in the company. As of 29 January 2021 there are in total 344,436,846 shares in the company, of which 14,765,620 of series A with ten votes each and 329,671,226 of series B with one vote each. The total number of votes in HEXPOL as of

INVISIO’s acquisition of Racal Acoustics completed. Management Group expanded.

INVISIO’s acquisition of Racal Acoustics is now completed. This strengthens INVISIO’s position as global market leader in advanced systems for communication and hearing protection for professional users. The acquisition of Racal Acoustics, which was announced on 22 December 2020, means that INVISIO is broadening its offer with a complementary product category consisting of advanced and robust hearing protection and communications headsets for environments with constant high noise. This type of environment is found for example in large military vehicles and around aircraft. The

The Nomination Committee’s proposal for election of Board members

The Nomination Committee of Pricer AB (publ) has decided to propose that the Annual General Meeting 2021 approve the following proposals regarding the number of Board members and election of Board members.The Nomination Committee proposes that the number of Board members be five (5). For the period until the end of the next Annual General Meeting, the Nomination Committee proposes re-election of Board members Knut Faremo, Hans Granberg, Jonas Guldstrand, Jenni Virnes, and furthermore proposes that Göran Sundholm be elected as a new Board member. Thomas Krishan has declined re-election.

Brighter terminates its financing arrangement with Unwrap Finance and intends to streamline operations

The Board of Directors of Brighter AB (publ) has decided to terminate its financing arrangement with Unwrap Finance, which has been one of the cornerstones in the financing of the Company's operations and is referred to in the financial reporting, and to focus instead on other financing solutions.  “The company is always evaluating available financing options. Building pre-payments into financial agreements with major customers/distributors at the contract stage is currently part of our primary strategy. Other priority options include traditional bank finance, loan finance, contract

Change in number of shares and votes in Arise AB (publ)

During January, the number of shares and votes in Arise AB (publ) has increased due to the conversion of convertibles issued under a preferential rights issue of convertibles in 2017. As of 29 January 2021, the number of shares and votes in Arise AB (publ) amounts to 37,094,230. Halmstad, 29 January 2021 ARISE AB (publ)                                        For further information, please contact:Linus Hägg, CFO Arise AB, +46 702 448 916 The information in the press release is such that Arise AB (publ) is required to disclose pursuant to the Swedish Financial Instruments

Eastnine resumes support for hospital staff and restaurants

Eastnine resumes support for hospital staff in Vilnius caring for patients infected with Covid-19. The food is delivered by three restaurants that are tenants at Eastnine.The second pandemic wave that began in late autumn 2020 hit Lithuania much harder than the first in spring 2020. Eastnine, which has a strong focus on sustainability and works to be a responsible player not only in the real estate market but also in the markets in which the company operates, has therefore resumed deliveries of meals to healthcare professionals treating patients with Covid-19 at a Vilnius hospital. “

Next Generation Warship Strategies Debated

ABS SVP Howard Fireman Moderates Panel of Senior Navy Executives (HOUSTON) The American Society of Naval Engineers (ASNE) Technology, Systems and Ships Virtual Symposium featured a panel moderated by ABS Senior Vice President Howard Fireman. The panel was titled A 21[st] Century Warship Design, Acquisition Strategy:  Meeting the Chief of Naval Operations Challenge.  The panel featured US Navy Senior Executive Service members John C. Hootman, Office of the Chief of Naval Operations, Deputy Director of Surface Warfare; Naval Sea Systems Commander; J. Carey Filling, Director,

Fast-growing Language and Technology Company Plint Appoints Thomas Roberts as New Chief Executive Officer

“I’m thrilled that Plint is now part of my story and to join a team helping people share their stories around the globe”, says Roberts.  Plint has appointed Thomas Roberts as new Chief Executive Officer, replacing Örjan Serner who has been acting CEO since March 2019. Most recently Roberts was Head of Development at Luxbright and before that he served as SVP for the EMEA region at Icomera – a global leader in mobile internet connectivity for public transport. At Icomera, he has held several VP roles with responsibilities including sales tactics, R&D, global marketing, and product

Volati continues growth with acquisition of JPT-Industria

Volati has acquired all shares in JPT-Industria OY, a leading supplier of equipment to the Finnish agricultural and food industry. The acquisition is an add-on acquisition for the Industry business area and the Tornum business unit. The acquisition expands Tornum’s offering within grain handling and gives the company a stronger market position in the Nordic region. JPT-Industria reported sales of EUR 7.5 million during the last financial year. JPT-Industria is an entrepreneurial company with about 35 employees and is headquartered in Ilmajoki in Finland. The company is a market-leading

Change in the number of shares and votes in AddLife AB

According to AddLife AB, org. no. 556995–8126, (“AddLife”) Articles of Association, the owner of Class A shares has the right to request that the share be converted into Class B shares. At the request of shareholders, 10,080 Class A shares were converted to 10,080 Class B shares. Following the conversion, the total number of shares and votes in AddLife as of January 29, 2021 amounts to 114,498,292 shares and 156,034,516 votes, respectively. 4,615,136 of these shares are Class A shares, representing 46,151,360 votes, and 109,883,156 are Class B shares, representing 109,883,156 votes.

Invitation to presentation of Handicares year-end report 2020

On 4 February at 08.00 a.m. (CET), Handicare will publish its year-end report for 2020. Please note that the date for publishing of the report has been changed from previously 12 February 2021. At 09.00 a.m. (CET) the same day, the company holds a conference call, where President and CEO Henrik Teiwik presents the report together with CFO Pernilla Lindén. After the presentation follows a Q&A session. The conference call will be held in English. The year-end report and a presentation will be available on the website, www.handicaregroup.com. After the conclusion of the conference call,

Adapteo completes the acquisition of Stord Innkvartering, the leading Norwegian provider of worker accommodation rental buildings

Adapteo Plc Press release 29 January 2021 at 1:30 p.m. CET Adapteo has completed the acquisition of Stord Innkvartering AS (Stord). Stord provides adaptable buildings within the infrastructure industry and public sector across Norway, including accommodation units, offices and canteens. Stord's building portfolio consists of approximately 4,000 units with approximately 110,000 square meters, and the company has an estimated market share of 10–15 per cent of the adaptable building market in Norway. For the financial year 2019, Stord had revenue of NOK 189 million, EBITDA of NOK 114

Avidly Oyj - Managers' Transactions - Maula

Avidly Oyj - Managers' Transactions - Maula Avidly Plc, Managers’ Transactions, 29 January 2021 at 2 p.m. EET Avidly Oyj - Managers' Transactions ____________________________________________ Person subject to the notification requirement Name: Maula, Jesse, Jouni, Sakari Position: Chief Executive Officer Issuer: Avidly Oyj LEI: 7437004G4SEVKZHT6O56 Notification type: INITIAL NOTIFICATION Reference number: 7437004G4SEVKZHT6O56_20210125073808_7 ____________________________________________ Transaction date: 2021-01-28 Venue not applicable Instrument

Announcement of terms for the fully guaranteed rights issue in OncoZenge, timetable for the listing and record date for Lex Asea

On November 16, 2020, OncoZenge AB (publ), Moberg Pharma's subsidiary, announced that the company had secured financing of a total of approximately SEK 70 million ahead of the spin-off and separate listing on Nasdaq First North Growth Market. Today, the Board of Moberg Pharma has decided that the record date for the right to receive shares in OncoZenge shall be February 5, 2021. The Board of OncoZenge has today, with the support of an authorization from an Extraordinary General Meeting on January 21, 2021, decided on the terms for the rights issue of approximately SEK 60 million (the “Rights

Announcement of terms for the fully guaranteed rights issue in OncoZenge, timetable for the listing and record date for Lex Asea

On November 16, 2020, OncoZenge AB (publ), Moberg Pharma's subsidiary, announced that the company had secured financing of a total of approximately SEK 70 million ahead of the spin-off and separate listing on Nasdaq First North Growth Market. Today, the Board of Moberg Pharma has decided that the record date for the right to receive shares in OncoZenge shall be February 5, 2021. The Board of OncoZenge has today, with the support of an authorization from an Extraordinary General Meeting on January 21, 2021, decided on the terms for the rights issue of approximately SEK 60 million (the “Rights

Avidly Oyj - Managers' Transactions - Nikkola

Avidly Oyj - Managers' Transactions - Nikkola Avidly Plc, Managers’ Transactions, 29 January 2021 at 2 p.m. EET Avidly Oyj - Managers' Transactions ____________________________________________ Person subject to the notification requirement Name: Nikkola, Ismo Position: Other senior manager Issuer: Avidly Oyj LEI: 7437004G4SEVKZHT6O56 Notification type: INITIAL NOTIFICATION Reference number: 7437004G4SEVKZHT6O56_20210125073719_7 ____________________________________________ Transaction date: 2021-01-28 Venue not applicable Instrument type: SHARE

There are no items matching the current filter
There are no more items matching the current filter
Back to top